TITLE

A robust method to derive functional neural crest cells from human pluripotent stem cells

AUTHOR(S)
Kreitzer, Faith R.; Salomonis, Nathan; Sheehan, Alice; Huang, Miller; Park, Jason S.; Spindler, Matthew J.; Lizarraga, Paweena; Weiss, William A.; Po-Lin So; Conklin, Bruce R.
PUB. DATE
April 2013
SOURCE
American Journal of Stem Cells;2013, Vol. 2 Issue 2, p119
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Neural crest (NC) cells contribute to the development of many complex tissues of all three germ layers during embryogenesis, and its abnormal development accounts for several congenital birth defects. Generating NC cells--including specific subpopulations such as cranial, cardiac, and trunk NC cells--from human pluripotent stem cells will provide a valuable model system to study human development and disease. Here, we describe a rapid and robust NC differentiation method called "LSB-short" that is based on dual SMAD pathway inhibition. This protocol yields high percentages of NC cell populations from multiple human induced pluripotent stem and human embryonic stem cell lines in 8 days. The resulting cells can be propagated easily, retain NC marker expression over multiple passages, and can spontaneously differentiate into several NC-derived cell lineages, including smooth muscle cells, peripheral neurons, and Schwann cells. NC cells generated by this method represent cranial, cardiac and trunk NC subpopulations based on global gene expression analyses, are similar to in vivo analogues, and express a common set of NC alternative isoforms. Functionally, they are also able to migrate appropriately in response to chemoattractants such as SDF-1, FGF8b, and Wnt3a. By yielding NC cells that likely represent all NC subpopulations in a shorter time frame than other published methods, our LSB-short method provides an ideal model system for further studies of human NC development and disease.
ACCESSION #
90174430

 

Related Articles

  • Small Molecule Screening with Laser Cytometry Can Be Used to Identify Pro-Survival Molecules in Human Embryonic Stem Cells. Sherman, Sean P.; Pyle, April D. // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    Differentiated cells from human embryonic stem cells (hESCs) provide an unlimited source of cells for use in regenerative medicine. The recent derivation of human induced pluripotent cells (hiPSCs) provides a potential supply of pluripotent cells that avoid immune rejection and could provide...

  • Skin Layer Grown from Stem Cells Could Replace Animal Testing.  // Bioscience Technology;Apr2014, p1 

    The article discusses the study on development of first laboratory-grown epidermis, outermost layer of the skin, with a functional permeability barrier similar to real skin, grown from human pluripotent stem cells, offering a cost-effective alternative model for drugs and cosmetics testing. It...

  • Corrigendum: Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Lister, Ryan; Pelizzola, Mattia; Kida, Yasuyuki S.; Hawkins, R. David; Nery, Joseph R.; Hon, Gary; Antosiewicz-Bourget, Jessica; O'Malley, Ronan; Castanon, Rosa; Klugman, Sarit; Downes, Michael; Yu, Ruth; Stewart, Ron; Ren, Bing; Thomson, James A.; Evans, Ronald M.; Ecker, Joseph R. // Nature;10/2/2014, Vol. 514 Issue 7520, p126 

    A correction to the article "Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cell" that was published in the March 03, 2011 issue is presented

  • Sherley v Sebelius and the Future of Stem Cell Research. Cohen, I. Glenn; Feigenbaum, Jeremy; Adashi, Eli Y. // JAMA: Journal of the American Medical Association;11/28/2012, Vol. 308 Issue 20, p2087 

    The authors offer information on the conflicts of federal funding associated with the first human embryonic stem cell (hESC) line research. They mention several factors of federal funding conflicts including legal, legislative and political. They discuss resolution of the legal challenge to the...

  • Down's Neurons from iPSCs Offer Clues. Breindl, Anette // BioWorld Today;6/3/2013, Vol. 24 Issue 105, Special section p1 

    The article discusses research on induced pluripotent stem cells (iPSCs) with a triplicate set of chromosome 21 in individuals with Down syndrome, published in the May 27, 2013 online issue of the "Proceedings of the National Academy of Sciences."

  • Briefings.  // American Scientist;Nov/Dec2014, Vol. 102 Issue 6, p409 

    The article presents abstracts on science topics in various periodicals including "Systematic Identification of Barriers to Human iPSC Generation" by H. Qin in the July 17, 2014 issue of "Cell," "The Laniakea Supercluster of Galaxies" by R. B. Tully, H. Courtois, Y. Hoffman, and D. Pomarede in...

  • What is the point of large-scale collections of human induced pluripotent stem cells? McKernan, Ruth; Watt, Fiona M // Nature Biotechnology;Oct2013, Vol. 31 Issue 10, p875 

    A letter to the editor is presented related to the study "What is the point of large-scale collections of human induced pluripotent stem cells" by Ruth McKernan and Fiona M Watt in October 2013 issue.

  • Program and Abstracts of the 12th Transgenic Technology Meeting (TT2014).  // Transgenic Research;Oct2014, Vol. 23 Issue 5, p827 

    The article presents abstracts on transgenic technology which include the research in induced pluripotent stem (iPS) cell technology and gene editing, in-vivo validation of cancer genes and drug targets, and embryonic stem cells.

  • 60 SECONDS.  // New Scientist;7/27/2013, Vol. 219 Issue 2927, p7 

    The article presents science news briefs on topics including the response of the World Health Organization to the Middle East coronavirus outbreak, confiscation of elephant tusks by Hong Kong customs agents on a ship from Togo, and clinical trials of induced pluripotent stem cells.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics